quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·450d
PRRelease
Cibus Inc. logo
Cellectis S.A. logo
Metagenomi Therapeutics Inc. logo
+1

Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

CBUS· Cibus Inc.CLLS· Cellectis S.A.MGX· Metagenomi Therapeutics Inc.CLXT· Calyxt Inc.
IndustrialsHealth Care
Original source

Companies

  • CBUS
    Cibus Inc.
    Industrials
  • CLLS
    Cellectis S.A.
    Health Care
  • MGX
    Metagenomi Therapeutics Inc.
    Health Care
  • CLXT
    Calyxt Inc.
    Industrials

Recent analyst ratings

  • Feb 17CLLSUpdateJefferies$7.00
  • Jul 29CBUSUpdateAlliance Global Partners$25.00
  • Jul 19CBUSUpdateCanaccord Genuity$22.00
  • May 7MGXUpdateH.C. Wainwright$10.00
  • May 2MGXUpdateJP Morgan$6.00
  • Mar 5MGXUpdateTD Cowen-

Related

  • SEC3d
    SEC Form DEFA14A filed by Cibus Inc.
  • SEC3d
    SEC Form DEF 14A filed by Cibus Inc.
  • INSIDER6d
    SEC Form 3 filed by new insider Urban Thomas
  • PR8d
    Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
  • PR9d
    Cibus Announces the Election of Thomas Urban to Board of Directors
  • SEC10d
    SEC Form 6-K filed by Cellectis S.A.
  • PR10d
    Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis' Allogeneic CAR-T Platform
  • SEC13d
    Cibus Inc. filed SEC Form 8-K: Leadership Update
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022